PHIO Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Trials Focus MYSZ Q4 2025 Earnings Significant EPS Miss Amid Revenue Uncertainty ENB Q1 2026 Earnings EPS Beat Bolsters Investor Confidence Amid Steady Operations LFST Q1 2026 Earnings A Massive EPS Surprise Overshadowed by Market Skepticism Nakamoto Inc NAKA Q4 2025 Earnings EPS Misses Estimates but Stock Surges 915 INAB Q1 2026 Earnings Narrowed Losses Exceed Expectations as Clinical Progress Continues